| EPB183 | Week 96 weight and lipid changes from baseline among participants receiving cabotegravir and rilpivirine long-acting or comparator therapy in the ATLAS-2M and FLAIR studies | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| OALBX0105 | Week 48 results of a Phase 3 randomized controlled trial of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) vs dolutegravir + emtricitabine/tenofovir Disoproxil Fumarate (DTG+F/TDF) as initial treatment in HIV/HBV-coinfected adults (ALLIANCE) | Oral abstract session with live Q&A | Viral hepatitis C and other viral hepatitis (e.g., A, B, D, E) |
| EPE364 | 'We should have access to information at our fingertips' ' results of a mixed methods study of data availability and use by decision makers for HIV programs in Blantyre, Malawi | E-poster | Approaches to using data to improve programming |
| EPD132 | We decide for ourselves! Community feedback on transgender persons (protection of rights) rules 2020: implications for social determinants of health and HIV | E-poster | Transgender people |
| EPE111 | 'We are equal': increasing service uptake through strategic communications | E-poster | Strategies to enhance U=U communication and implementation |
| EPF161 | Water and food insecurity are linked with increased HIV vulnerabilities during the COVID-19 pandemic among urban refugee youth in Kampala, Uganda | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |
| EPB047 | Voriconazole or amphotericin B deoxycholate: which is the preferred induction therapy in HIV-infected patients with talaromycosis? | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPE393 | Voluntary Medical Male Circumcision (VMMC) service model rebranding amidst novel corona virus-19 (COVID-19) pandemic in meeting set targets in Zambia | E-poster | Impact of COVID-19 on HIV prevention services |
| EPA085 | Vitamin D supplementation enhances cytotoxic response in patients with severe COVID-19 | E-poster | Immune responses to SARS-Cov2 |
| EPD001 | Visual access to create greater comprehension: Incorporating the visual arts into a representational analysis of HIV community dialogue on living with HIV and a quality of life | E-poster | Community engagement in research and research dissemination |